Correlation Between Crinetics Pharmaceuticals and Nuvalent
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Nuvalent, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Nuvalent.
Diversification Opportunities for Crinetics Pharmaceuticals and Nuvalent
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Crinetics and Nuvalent is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Nuvalent go up and down completely randomly.
Pair Corralation between Crinetics Pharmaceuticals and Nuvalent
Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to under-perform the Nuvalent. In addition to that, Crinetics Pharmaceuticals is 1.5 times more volatile than Nuvalent. It trades about -0.21 of its total potential returns per unit of risk. Nuvalent is currently generating about -0.13 per unit of volatility. If you would invest 9,562 in Nuvalent on October 26, 2024 and sell it today you would lose (1,298) from holding Nuvalent or give up 13.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crinetics Pharmaceuticals vs. Nuvalent
Performance |
| Timeline |
| Crinetics Pharmaceuticals |
| Nuvalent |
Crinetics Pharmaceuticals and Nuvalent Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crinetics Pharmaceuticals and Nuvalent
The main advantage of trading using opposite Crinetics Pharmaceuticals and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.| Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
| Nuvalent vs. Arcellx | Nuvalent vs. Vaxcyte | Nuvalent vs. Viridian Therapeutics | Nuvalent vs. Ventyx Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |